Skip to main content
. 2017 Aug 2;37(4):BSR20170121. doi: 10.1042/BSR20170121

Figure 2. Kaplan–Meier survival curves of patients with different HER-2 expression and SLN metastasis.

Figure 2

(A) DFS survival curve of HER-2, with P<0.05 examined by Log-rank test. (B) OS survival curve of HER-2, with P<0.05 examined by Log-rank test. (C) DFS survival curve of SLN metastasis, with P<0.05 examined by Log-rank test. (D) OS survival curve of SLN metastasis, with P<0.05 examined by Log-rank test.